Ultima drostan e 200
Ultima-Drostan E 200 is an illegal, black-market injectable anabolic-androgenic steroid (AAS). It contains drostanolone enanthate at a concentration of 200 milligrams per milliliter (mg/ml). The product is produced in unregulated laboratories by an illicit company, Ultima Ultima drostan e 200 Pharmaceuticals, and is not approved for human medical use.
Active substance: Drostanolone enanthate
- Medical origin: Drostanolone (also known as dromostanolone) was formerly used to treat advanced breast cancer in postmenopausal women.
- Mechanism: It works by attaching to androgen receptors, which can help block the growth of certain types of breast cancer cells. It is also known for its strong androgenic properties.
- Illegal use: Bodybuilders and athletes illegally acquire drostanolone to increase muscle hardness, improve definition, and build strength, particularly during “cutting cycles” for fat loss.
Significant risks
As a black-market product, Ultima Drostan E 200 is not subject to quality control, meaning its purity, sterility, and actual concentration are unknown. Its misuse carries significant health risks.
Cardiovascular effects:
- Increased blood pressure.
- Unhealthy cholesterol levels (often increasing “bad” LDL cholesterol and lowering “good” HDL cholesterol).
- Increased risk of heart attack, stroke, and blood clots.
Hormonal dysfunction:
- Suppression of the body’s natural testosterone production, leading to testicular shrinkage and infertility in men.
- The steroid’s use disrupts the body’s natural hormonal balance, which can lead to significant issues during and after a cycle.
Psychological effects:
- Severe mood swings and increased aggression (“roid rage”).
- Anxiety, paranoia, and depression.
Androgenic side effects:
- Severe acne and oily skin.
- Accelerated male-pattern hair loss in predisposed individuals.
- Can cause virilization (the development of masculine features) in women, which can be irreversible.
Other risks:
- Potential for severe liver and kidney damage.
- Risk of infection from non-sterile manufacturing processes or improper injection techniques





Be the first to review “Ultima-Drostan E 200”